Skip to main content

and
  1. No Access

    Article

    Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain

    The objective of this paper was to assess the cost–utility of fidaxomicin versus vancomycin in the treatment of Clostridium difficile infection (CDI) in three specific CDI patient subgroups: those with cancer, tr...

    C. Rubio-Terrés, J. Cobo Reinoso in European Journal of Clinical Microbiology … (2015)

  2. Article

    Open Access

    Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism

    Patients with venous thromboembolism (VTE) commonly have an underlying genetic predisposition. However, genetic tests nowadays in use have very low sensitivity for identifying subjects at risk of VTE. Thrombo ...

    C. Rubio-Terrés, J. M. Soria, P. E. Morange in Applied Health Economics and Health Policy (2015)

  3. Article

    Open Access

    Economic Evaluation of Cardio inCode®, a Clinical-Genetic Function for Coronary Heart Disease Risk Assessment

    A clinical–genetic function (Cardio inCode®) was generated using genetic variants associated with coronary heart disease (CHD), but not with classical CHD risk factors, to achieve a more precise estimation of the...

    A. Ramírez de Arellano, A. Coca in Applied Health Economics and Health Policy (2013)

  4. No Access

    Article

    Validación del cuestionario “Diabetes treatment satisfaction questionnaire” (DTSQ) en la población española

    Objetivos: El objetivo del estudio fue evaluar las propiedades psicométricas de la versión española del cuestionario DTSQ (en las versiones estado y cambio), diseñado para medir la satisfacción y...

    Ramón Gomis, J. L. Herrera-Pombo in PharmacoEconomics Spanish Research Articles (2006)

  5. No Access

    Article

    Análisis farmacoeconómico del tratamiento de pacientes con exacerbación aguda de la bronquitis crónica con cefditoren pivoxilo o cefuroxima axetilo

    Objetivo: comparar la eficiencia de dos tratamientos antibióticos en la exacerbación aguda de la bronquitis crónica (EABC): cefditoren pivoxilo (CDTR-PI) y cefuroxima axetilo (CXA).

    C. Rubio-Terrés, A. Domínguez-Gil in PharmacoEconomics Spanish Research Articles (2005)

  6. Article

    40th EASD Annual Meeting of the European Association for the Study of Diabetes

    M. Veitenhansl, K. Stegner, F.-X. Hierl, C. Dieterle, H. Feldmeier, B. Gutt in Diabetologia (2004)